Eisai Enters Into Co-Promotion Agreement With Biogen

Gilbert and Sharp went on to receive Nobel Prizes: Gilbert was awarded the Nobel Prize in Chemistry in 1980 for his work in understanding DNA sequencing, while Sharp was awarded the Nobel Prize in Physiology or Medicine in 1993 for his discovery of divided genes. “With this new agreement, we believe we have enhanced our ability to maximize the value of aducanumab and expand the potential reach of our leading multiple sclerosis portfolio,” said Michel Vounatsos, Chief Executive Officer of Biogen. “The ongoing cooperation between Biogen and Eisai leverages our respective expertise and strengths in our efforts to provide new treatments for patients and families affected by Alzheimer`s disease.” Eisai and Biogen will cooperate to strengthen patient contributions in Japan and Asia (excluding China) through Biogen`s anti-SCLEROSIS treatments. .

Comments are closed.